An observational study of oral tofacitinib, baricitinib, upadacitinib and systemic steroids in refractory vitiligo, Mendeley Supplements.
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://data.mendeley.com/datasets/hhpdcvwtk3
下载链接
链接失效反馈官方服务：
资源简介：
1. Supplemental Materials including:
Supplementary Figure 1: The VASI score in four groups at month 0, 3, and 6.
Supplementary Figure 2: The VASI improvement in four groups at month 0, 3, and 6.
Supplementary Figure 3: Serum levels of CXCL10 and CCL20 in four groups at month 0, 3, and 6.
Supplementary Figure 4: Clinical photographs using a wood light of 4 patients receiving different monotherapy during the follow-up. (T, tofacitinib; B, baricitinib; U, upadacitinib; S, steroids).
2.Supplemental Methods
创建时间：
2023-11-29
